Aperio Group, LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$94,000
+1.1%
13,226
+3.0%
0.00%0.0%
Q2 2017$93,000
+22.4%
12,844
+3.8%
0.00%0.0%
Q1 2017$76,000
+13.4%
12,372
+8.9%
0.00%0.0%
Q4 2016$67,000
+15.5%
11,362
+3.7%
0.00%
Q3 2016$58,000
+52.6%
10,959
+2.8%
0.00%
Q3 2015$38,000
-71.6%
10,664
+1.2%
0.00%
-100.0%
Q1 2015$134,000
-41.0%
10,539
-34.4%
0.00%
-33.3%
Q4 2014$227,000
+16.4%
16,074
+13.2%
0.00%0.0%
Q3 2014$195,000
-3.5%
14,196
+8.2%
0.00%0.0%
Q2 2014$202,00013,1250.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$30.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders